Cargando…
Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer
Next generation sequencing is transforming patient care by allowing physicians to customize and match treatment to their patients’ tumor alterations. Our goal was to study the association between key molecular alterations and outcome parameters. We evaluated the characteristics and outcomes (overall...
Autores principales: | Schwaederle, Maria, Daniels, Gregory A, Piccioni, David E, Kesari, Santosh, Fanta, Paul T, Schwab, Richard B, Shimabukuro, Kelly A, Parker, Barbara A, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614790/ https://www.ncbi.nlm.nih.gov/pubmed/25928476 http://dx.doi.org/10.1080/15384101.2015.1033596 |
Ejemplares similares
-
Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
por: Kato, Shumei, et al.
Publicado: (2015) -
Telomerase Reverse Transcriptase Promoter Alterations Across Cancer Types as Detected by Next-Generation Sequencing: A Clinical and Molecular Analysis of 423 Patients
por: Schwaederle, Maria, et al.
Publicado: (2017) -
Cyclin alterations in diverse cancers: outcome and co-amplification network
por: Schwaederlé, Maria, et al.
Publicado: (2014) -
Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics
por: Parish, A, et al.
Publicado: (2015) -
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology
por: Patel, Sandip P., et al.
Publicado: (2015)